Pharma loses battle in bid to block drug importation from Canada

In a setback to the pharmaceutical industry, a federal judge has tossed a lawsuit that sought to prevent state governments from importing medicines from Canada. The decision is likely to embolden more states to now consider the approach as they look to lower the cost of prescription drugs

In a 26-page opinion, U.S. District Court Judge Timothy Kelly ruled that drug companies failed to prove they would face a “concrete risk of harm” from a federal rule that would allow states to import medicines. In his view, any harm is only speculative, because there is no guarantee the federal government will approve any state proposal. As a result, the industry did not have standing to file suit.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

No Byline Policy

Editorial Guidelines

Corrections Policy

Source